OBJECTIVE: To investigate the role of SMN1 and SMN2 copy number variation and point mutations in amyotrophic lateral sclerosis (ALS) pathogenesis in a large population. METHODS: We conducted a genetic association study including 847 patients with ALS and 984 controls. We used multiplexed ligation-dependent probe amplification (MLPA) assays to determine SMN1 and SMN2 copy numbers and examined effects on disease susceptibility and disease course. Furthermore, we sequenced SMN genes to determine if SMN mutations were more prevalent in patients with ALS. A meta-analysis was performed with results from previous studies. RESULTS: SMN1 duplications were associated with ALS susceptibility (odds ratio [OR] 2.07, 95% confidence interval [CI] 1.34-3.20, p = 0.001). A meta-analysis with previous data including 3,469 individuals showed a similar effect: OR 1.85, 95% CI 1.18-2.90, p = 0.008). SMN1 deletions and SMN2 copy number status were not associated with ALS. SMN1 or SMN2 copy number variants had no effect on survival or the age at onset of the disease. We found no enrichment of SMN point mutations in patients with ALS. CONCLUSIONS: Our data provide firm evidence for a role of common SMN1 duplications in ALS, and raise new questions regarding the disease mechanisms involved.
OBJECTIVE: To investigate the role of SMN1 and SMN2 copy number variation and point mutations in amyotrophic lateral sclerosis (ALS) pathogenesis in a large population. METHODS: We conducted a genetic association study including 847 patients with ALS and 984 controls. We used multiplexed ligation-dependent probe amplification (MLPA) assays to determine SMN1 and SMN2 copy numbers and examined effects on disease susceptibility and disease course. Furthermore, we sequenced SMN genes to determine if SMN mutations were more prevalent in patients with ALS. A meta-analysis was performed with results from previous studies. RESULTS:SMN1 duplications were associated with ALS susceptibility (odds ratio [OR] 2.07, 95% confidence interval [CI] 1.34-3.20, p = 0.001). A meta-analysis with previous data including 3,469 individuals showed a similar effect: OR 1.85, 95% CI 1.18-2.90, p = 0.008). SMN1 deletions and SMN2 copy number status were not associated with ALS. SMN1 or SMN2 copy number variants had no effect on survival or the age at onset of the disease. We found no enrichment of SMN point mutations in patients with ALS. CONCLUSIONS: Our data provide firm evidence for a role of common SMN1 duplications in ALS, and raise new questions regarding the disease mechanisms involved.
Authors: C F Rochette; L C Surh; P N Ray; P E McAndrew; T W Prior; A H Burghes; M Vanasse; L R Simard Journal: Neurogenetics Date: 1997-09 Impact factor: 2.660
Authors: J H Veldink; L H van den Berg; J M Cobben; R P Stulp; J M De Jong; O J Vogels; F Baas; J H Wokke; H Scheffer Journal: Neurology Date: 2001-03-27 Impact factor: 9.910
Authors: Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals Journal: Nucleic Acids Res Date: 2002-06-15 Impact factor: 16.971
Authors: P Corcia; W Camu; J-M Halimi; P Vourc'h; C Antar; S Vedrine; B Giraudeau; B de Toffol; C R Andres Journal: Neurology Date: 2006-08-23 Impact factor: 9.910
Authors: J H Veldink; S Kalmijn; A H Van der Hout; H H Lemmink; G J Groeneveld; C Lummen; H Scheffer; J H J Wokke; L H Van den Berg Journal: Neurology Date: 2005-08-10 Impact factor: 9.910
Authors: Philippe Corcia; Véronique Mayeux-Portas; Jawad Khoris; Bertrand de Toffol; Alain Autret; Jean-Pierre Müh; William Camu; Christian Andres Journal: Ann Neurol Date: 2002-02 Impact factor: 10.422
Authors: Barbara E Stranger; Matthew S Forrest; Mark Dunning; Catherine E Ingle; Claude Beazley; Natalie Thorne; Richard Redon; Christine P Bird; Anna de Grassi; Charles Lee; Chris Tyler-Smith; Nigel Carter; Stephen W Scherer; Simon Tavaré; Panagiotis Deloukas; Matthew E Hurles; Emmanouil T Dermitzakis Journal: Science Date: 2007-02-09 Impact factor: 47.728
Authors: Natalia Rodriguez-Muela; Nadia K Litterman; Erika M Norabuena; Jesse L Mull; Maria José Galazo; Chicheng Sun; Shi-Yan Ng; Nina R Makhortova; Andrew White; Maureen M Lynes; Wendy K Chung; Lance S Davidow; Jeffrey D Macklis; Lee L Rubin Journal: Cell Rep Date: 2017-02-07 Impact factor: 9.423
Authors: Marka van Blitterswijk; Bianca Mullen; Michael G Heckman; Matthew C Baker; Mariely DeJesus-Hernandez; Patricia H Brown; Melissa E Murray; Ging-Yuek R Hsiung; Heather Stewart; Anna M Karydas; Elizabeth Finger; Andrew Kertesz; Eileen H Bigio; Sandra Weintraub; Marsel Mesulam; Kimmo J Hatanpaa; Charles L White; Manuela Neumann; Michael J Strong; Thomas G Beach; Zbigniew K Wszolek; Carol Lippa; Richard Caselli; Leonard Petrucelli; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; Ian R Mackenzie; William W Seeley; Lea T Grinberg; Bruce L Miller; Kevin B Boylan; Neill R Graff-Radford; Bradley F Boeve; Dennis W Dickson; Rosa Rademakers Journal: Neurobiol Aging Date: 2014-05-02 Impact factor: 4.673
Authors: Maria Dimitriadi; Min Jeong Kye; Geetika Kalloo; Jill M Yersak; Mustafa Sahin; Anne C Hart Journal: J Neurosci Date: 2013-04-10 Impact factor: 6.167
Authors: Jeroen W Bos; Ewout J N Groen; Renske I Wadman; Chantall A D Curial; Naomi N Molleman; Marinka Zegers; Paul W J van Vught; Reinier Snetselaar; Raymon Vijzelaar; W Ludo van der Pol; Leonard H van den Berg Journal: Neurol Genet Date: 2021-06-22